Market for Prophylactic Medicaments Containing Insulin in Libya
The value of the prophylactic medicaments containing insulin market in Libya surged to $ in , picking up by % against the previous year. This figure reflects the total revenues of producers and importers (excluding logistics costs, retail marketing costs, and retailers' margins, which will be included in the final consumer price). In general, consumption showed prominent growth. Over the period under review, the market hit record highs at $ in 2012; however, from 2013 to , consumption remained at a lower figure.